- Home
- HQL vs EHAB Comparison
HQL vs EHAB Comparison
Compare HQL & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQL
- EHAB
- Stock Information
- Founded
- HQL 1992
- EHAB 2014
- Country
- HQL United States
- EHAB United States
- Employees
- HQL N/A
- EHAB N/A
- Industry
- HQL Investment Managers
- EHAB Hospital/Nursing Management
- Sector
- HQL Finance
- EHAB Health Care
- Exchange
- HQL Nasdaq
- EHAB Nasdaq
- Market Cap
- HQL 440.3M
- EHAB 403.5M
- IPO Year
- HQL N/A
- EHAB N/A
- Fundamental
- Price
- HQL $16.88
- EHAB $8.07
- Analyst Decision
- HQL
- EHAB Buy
- Analyst Count
- HQL 0
- EHAB 3
- Target Price
- HQL N/A
- EHAB $8.67
- AVG Volume (30 Days)
- HQL 120.9K
- EHAB 394.4K
- Earning Date
- HQL 01-01-0001
- EHAB 11-05-2025
- Dividend Yield
- HQL 11.56%
- EHAB N/A
- EPS Growth
- HQL N/A
- EHAB N/A
- EPS
- HQL 0.79
- EHAB N/A
- Revenue
- HQL N/A
- EHAB $1,047,800,000.00
- Revenue This Year
- HQL N/A
- EHAB $4.95
- Revenue Next Year
- HQL N/A
- EHAB $4.51
- P/E Ratio
- HQL $17.08
- EHAB N/A
- Revenue Growth
- HQL N/A
- EHAB 1.02
- 52 Week Low
- HQL $11.34
- EHAB $6.47
- 52 Week High
- HQL $14.37
- EHAB $10.91
- Technical
- Relative Strength Index (RSI)
- HQL 56.62
- EHAB 47.89
- Support Level
- HQL $15.67
- EHAB $7.58
- Resistance Level
- HQL $17.10
- EHAB $8.23
- Average True Range (ATR)
- HQL 0.39
- EHAB 0.31
- MACD
- HQL -0.10
- EHAB -0.04
- Stochastic Oscillator
- HQL 56.79
- EHAB 41.23
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.